Inflammatory Disease: New Therapy Approved in Argentina for the Treatment of Adult Patients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Inflammatory bowel diseases (IBDs) represent a growing challenge for health systems around the world. They are chronic conditions that cause persistent inflammation in the digestive system and that significantly impact the daily lives of those who suffer from them. Within this group, the most common are Crohn’s disease and ulcerative colitis. Both can generate symptoms such as abdominal pain, recurrent diarrhea, rectal bleeding, extreme fatigue …
Buenos Aires, 7 June (NA) -- Inflammatory bowel disease (IBD) is a group of chronic conditions that cause inflammation and swelling in the digestive tract and that includes mainly two, ulcerative colitis and Crohn's disease, the first is a condition that causes inflammation in the lining of the colon and rectum, while the second involves inflammation of the digestive tract, affecting mainly the small intestine, colon and upper gastrointestinal t…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
